FundaMental Pharma
Germany - HeidelbergPharmaceutical
Focus: FundaMental Pharma is a newly-founded (2023) German biotech developing small molecule inhibitors for neurodegenerative diseases, operating as a publicly-listed entity from Heidelberg. The company maintains a lean, early-stage profile with 22 active job openings and a diversified pipeline spanning neurology and adjacent therapeutic areas.
Profile data last refreshed 7h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
25+6 this month
Growing — net +6 jobs in 30d
8 jobs added vs 2 removed. Steady team buildout.
Should You Work at FundaMental Pharma?
AI assessmentEarly-stage bet for risk-tolerant professionals seeking ground-floor equity and tech-driven biotech culture, but limited clinical validation, narrow cash runway visibility, and pipeline coherence concerns warrant due diligence on capitalization and leadership vision.
Why Work Here
- Ground-floor opportunity at a newly-public company with 22 active roles, suggesting aggressive expansion phase and clear career trajectory potential.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
11 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Stem Cell Transplantation
Spinal Cord InjuryClinical Trials (1)
NCT01325103Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury
N/AHelp build intelligence for FundaMental Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.